Inactive Instrument

News Iqvia Holdings Inc Nyse

Equities

IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024	May. 09	BU
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294	May. 07	MT
UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating	May. 03	MT
Deutsche Bank Adjusts Price Target on IQVIA Holdings to $275 From $280	May. 03	MT
Jefferies Adjusts Price Target on IQVIA to $266 From $281	May. 03	MT
Morgan Stanley Adjusts Price Target on IQVIA to $270 From $275	May. 03	MT
Truist Adjusts IQVIA Holdings' Price Target to $292 From $297, Keeps Buy Rating	May. 03	MT
Baird Adjusts Price Target on IQVIA to $245 From $254	May. 03	MT
Leerink Partners Adjusts Price Target on IQVIA to $278 From $290	May. 03	MT
Evercore ISI Adjusts Price Target on IQVIA to $250 From $275	May. 03	MT
IQVIA trims full-year revenue forecast on stronger dollar	May. 02	RE
Transcript : IQVIA Holdings Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
IQVIA Holdings Q1 Adjusted Earnings, Revenue Increase	May. 02	MT
Earnings Flash (IQV) IQVIA HOLDINGS Reports Q1 Revenue $3.74B, vs. Street Est of $3.71B	May. 02	MT
Earnings Flash (IQV) IQVIA HOLDINGS Reports Q1 EPS $2.54, vs. Street Est of $2.48	May. 02	MT
IQVIA: Q1 Earnings Snapshot	May. 02	AQ
IQVIA Reports First-Quarter 2024 Results	May. 02	BU
IQVIA Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
North American Morning Briefing : Stock Futures -2-	May. 02	DJ
Market Share of Celltrion’s Remsima Rises to 74% in Europe	Apr. 24	MT

No results for this search